ROCHE HLDG DR risk profile
27 Normal where most of the sector sits
Measured 1 September 2026 from RHO5's filed statements. Recomputed nightly.
27 (Normal), driven by Market expectation at 37, over 4 weighted categories on the GENERAL profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 37 | Normal | Stable | Average daily turnover — $5.1K |
| Operating pressure | 25 | Normal | Stable | Operating-margin drift — +2.6 percentage points |
| Cash conversion | 24 | Normal | Worsening | Capital spending against operating cash — 0.31x |
| Leverage and coverage | 22 | Normal | Easing | Current ratio — 1.38x |
| Competitive position | Reads research_and_development, operating_income, revenue, peer cohort and disclosed transition KPIs. No reading is stored for this company. | |||
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.